Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Esophagus
Published in: Esophagus 2/2005

01-06-2005 | CASE REPORT

Esophageal composite carcinoma with tripartite differentiation: clinicopathological analysis of three cases

Authors: Tadashi Tanabe, Tadashi Nishimaki, Tatsuo Kanda, Satoru Nakagawa, Manabu Ohashi, Katsuyoshi Hatakeyama

Published in: Esophagus | Issue 2/2005

Login to get access
Metadata
Title
Esophageal composite carcinoma with tripartite differentiation: clinicopathological analysis of three cases
Authors
Tadashi Tanabe
Tadashi Nishimaki
Tatsuo Kanda
Satoru Nakagawa
Manabu Ohashi
Katsuyoshi Hatakeyama
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Esophagus / Issue 2/2005
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-005-0039-3

Other articles of this Issue 2/2005

Esophagus 2/2005 Go to the issue

ORIGINAL ARTICLE

Expression of E-cadherin, cyclin D1, matrix metalloproteinase 9, and vascular endothelial growth factor in primary tumor of esophageal squamous cell carcinoma does not predict lymph node micrometastasis

CASE REPORT

Preoperative chemoradiotherapy and surgery for locally advanced esophageal basaloid squamous carcinoma: report of successful

SPECIAL ARTICLE

Comprehensive registry of esophageal cancer in Japan, 1999

ORIGINAL ARTICLE

Radiation therapy for esophageal cancer: results of the patterns of Care Study in Japan 1995–1997

CASE REPORT

Stenting for ischemic tracheal stricture following surgery for esophageal cancer

CASE ATLAS

Superficial esophageal cancer type 0-IIc, sm1
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits